Terra Tech Corp (OTCMKTS:TRTC) Provides Company and Industry Update

Terra Tech Corp (OTCMKTS:TRTC) has announced that its CEO Derek Peterson was recently interviewed by, in which he provided an industry and company update. The audio interview has been made available on the company website. In his interview, Mr. Peterson discussed the recent election, cabinet appointments and the outlook of the company. He also discussed the state of the cannabis industry and the legalization in Nevada and California.

Separately, the CEO voiced his belief that the incoming government would respect the rights of states to make autonomous decisions, thereby allowing the cannabis industry to thrive. He also pointed out that the president-elect has already claimed that cannabis regulations would be decided on a state-by-state basis, which also indicate that he is aware of the economic benefits the industry has to offer.

Mr. Peterson also stated that a significant amount of tax revenues are being generated, through the industry, since approximately half of the US states have legalized marijuana for medical or recreational use. He also dismissed the beliefs that the new administration might not favor state-level legalization, by claiming that the overwhelming response in favor of marijuana legalization, observed on election day, would make lawmakers reluctant to stifle the new industry.

Terra Tech has also been gaining a lot of attention from analysts of the cannabis industry, which can be seen by the fact that its CEO was recently appointed to the Q&A panel of the Arcview Investor Forum, held in Las Vegas. The event was held on November 15, 2016 and is aimed at helping new and upcoming cannabis companies, network and collaborate with investors. The Arcview Angel Network, which organizes the forum, has over 550 accredited investors and has so far helped over 133 cannabis companies, in raising funds. The event is held on a quarterly basis and is comprised of in-person pitch, which are analyzed by the panel. Mr. Peterson’s inclusion hints that TRTC is being widely viewed as a successful company in the industry.

Terra Tech Corp (OTCMKTS:TRTC) closed at a share price of $0.292, at the end of the November 23 trading session, 10% higher than the day before.

Marijuana MMJ

Medical Marijuana Inc (OTCMKTS:MJNA)’s Mexican Arm Featured In Newsweek

Medical Marijuana Inc (OTCMKTS:MJNA) has stated that its Mexican subsidiary, HempMeds has been featured in Newsweek. The company stated that the coverage focused on Real Scientific Hemp Oil-X, a non-psychoactive, THC free hemp based CBD product from HempMeds. It should be noted here that RSHO-X is the first federally approved product in Mexico and was featured in the October 24 version of Newsweek.

In addition to this, the story features the legal status of the cannabis industry in Mexico, the growing market in California and the story of a little girl suffering from epilepsy and how RSHO-X was able to help her. Moreover, the article also features details of MJNA’s growing presence in the Latin American market and how quickly HempMeds is gaining popularity in the country. The CEO of Medical Marijuana, Dr. Stuart Titus, has claimed that the expansion in Latin America is poised to bring substantial economic growth to the company.

Separately, the company announced that HempMeds has opened a new office in Monterey, Mexico, which would be the new headquarters for its Mexican operations. Added to this, the company has also added Carlos Gonzales, as the new COO of HempMeds. Specifically, Mr. Gonzales would focus on improving the sales and distribution of products, from MJNA’s Mexican subsidiary, specially RSHO-X. Dr. Titus commented on the recent developments, stating that the new office provides them with the opportunity to conduct on-ground operations. He further stated that this would help strengthen their relations with the Mexican government, as they continue to educate lawmakers and health officials about the benefits of CBD.

The CEO also welcomed Mr. Gonzales to the management team and expressed confidence in his ability to perform in the Mexican market. It should be noted here that currently RSHO-X has been cleared for the treatment of neuropathic conditions, related to diabetes. Moreover, MJNA believes that its research could possibly lead to the discovery of CBD based treatments for neuro-degenerative and neurological disorders.

Medical Marijuana Inc (OTCMKTS:MJNA) completed the November 23 trading session with a gain of 30.12% in terms of its share value, to reach a close at $0.108 per share.

Marijuana MMJ

General Cannabis Corp (OTCMKTS:CANN) Appoints New Director To The Board

General Cannabis Corp (OTCMKTS:CANN) has announced that Duncan Levin has been elected to the company’s board of directors. Mr. Levin is currently the managing partner of Tucker Levin, PLLC and is also a former federal prosecutor. Added to this, he is an expert in the legal aspects of anti-money laundering, anti-fraud and internal investigations. However, more recently he has been working as a consultant for businesses facing anti-fraud, regulatory issues and other complex challenges.

Robert Frichtel, the CEO of CANN, stated that the new director’s background and expertise would help elevate the company, to a whole new level of professionalism. He further went on to state that Mr. Levin’s unique perspective on legal matters would help General Cannabis in moving through uncharted territory. Mr. Frichtel also voiced his optimism by stating that the new director could help General Cannabis in becoming a premier consultant in this field.

Commenting on his appointment, Mr. Levin claimed that General Cannabis is destined to become a leader in the industry and it was a delight to join the board at a time of immense growth. He also stated that the cannabis industry was one of the fastest growing industries in the country and with the wide array of support services offered by General Cannabis, it could very well become a leader in the field. Mr. Levin’s appointment comes soon after the company attended the Marijuana Business Conference & Expo, in Las Vegas.

CANN attended the event on November 16-18, where it got the opportunity to meet investors and other business leaders from the industry. It should be noted here that this conference is considered to be one of the premier marijuana conferences of the year. The event was attended by almost the entire management of the company. Moreover, General Cannabis also hosted an after party on November 16, in honor of the legalization of marijuana in several states.

General Cannabis Corp (OTCMKTS:CANN) lost 11.01% of its share value, during the November 22 trading session, to reach a close at $3.07 per share. The stock had a trade volume of 557,331, during the session.


The Good And The Bad About Canopy Growth Corp (TSE:CGC)

Canopy Growth Corp (CGC) rallying by more than 370% over the last three months is a testament that investors are slowly taking note of opportunities in the cannabis sector. Investors have especially become inquisitive about the Canadian company, given that it boasts a market cap of over $800 million, a feat that is unique in the industry.

 The Good

Interest In the stock has not only been fueled by development in the US on the legalization of Marijuana in eight new states, but the fact that Canada could also legalize the plant. Justin Trudeau government has already given the clearest of indication of its willingness to legalize marijuana for medical purposes. Such a move would essentially lead to the expansion of the target market for Canopy growth, which has already shown what it can do.

Canopy growth is by far the biggest marijuana operator in North America having already accrued a substantial amount of market share in the first growing business. The company’s business model revolves around renting warehouses and using them to grow pot. Its business model places it at the heart of the industry with the expected growth in demand for the plant.

 The Bad

Amidst the impressive run that is unmatched by other stock’s in the industry, the stock faces an uphill task to maintain its recent upward momentum. The entry of professional investors into the industry is one that could spell trouble for the stock as its valuation comes under scrutiny.

A point of concern on the valuation point is the fact that the company generated $18 million in revenue over the last 12 months and still posted a net loss of $8 million. Cash flow of negative $13 million is another red flag for a company that already boasts a valuation of over $800 million.

While the future looks bright for Canopy Growth Corp (CGC) growth, the threat of competition is one that could curtail its impressive run. With the stock trading at highs of $10.48 a share, it awaits to be seen if it will continue powering higher ahead of its 52-week high of $17.86 a share.

Marijuana MMJ

How Insurance Competition Could Fuel Expansion Canada’s Cannabis Industry

The legal marijuana industry in Canada recently received a major boost thanks to competition among health underwriters. Two major Canadian insurance companies recently made a historic move by easing the premium burden on cannabis users, a move that could be copied by other health insurers as competition for customers continues to heat up.

Sun Life and BMO Insurance have decided to treat marijuana users differently than they treat tobacco smokers. Until they made the move, all insurers in Canada classified any policyholder who disclosed using marijuana as a smoker. With that, the underwriters heaped on them the burn of nearly triple the premium they charge non-smokers.

But in the latest development, Sun Life and BMO have decided to draw a distinction between those smoke tobacco and those who use medical or creational cannabis. The insurers said their move was informed by fresh health research findings that have shown that smoking marijuana doesn’t carry the same health risks as smoking tobacco. In a statement, Sun Life said that cannabis users who apply for cover with the company are now put on non-smoker rates unless they also smoke tobacco.

A bit limited room

Although Sun Life’s new policy has let the door wide open for all marijuana users to enjoy cheaper premiums, BMO’s version appears a bit limited. For example, cannabis users applying for BMO coverage can only enjoy lower premium rates if they don’t smoke more than two marijuana cigarettes per week.

The move by Sun Life and BMO to reclassify marijuana users as non-smokers comes at a time when the federal government is in the process of legalizing creational cannabis usage.

Fueling grow of cannabis industry

The decision by Sun Life and BMO to drop exorbitant rates for marijuana smokers could be what triggers rapid growth of Canada’s legal marijuana industry. In the battle for customers, it is highly likely that other Canadian insurers will join Sun Life and BMO in reclassifying marijuana smokers. That should encourage more cannabis consumption for creation and medication purposes because many people have been holding themselves back for fear of being slapped with expensive life policies.

Marijuana MMJ

Ohio Lawmakers Admit That Medical Marijuana Is all Ohioans Need

Both chambers of the state’s Republican-led legislature have approved legislation that will lead to the legalization of marijuana use but only for medical purposes. The measure which passed by just a margin of three votes now awaits the approval of the Republican Governor John Kasich.

According to Sen. Kenny Yuko, marijuana legalization will go a long way in decreasing the suffering of many Ohioans. The proposal sounds limiting given that its users cannot smoke or grow it at home and must be in distress of a particular medical condition.

However, it can still be used in vapor form especially by those who suffer from chronic diseases. The bill is not at its best, but it is better than nothing. It will nonetheless, need regulation and licensing, tasks that should be carried out by the State Department of Commerce.

Previously, doctors could not recommend marijuana to their patients for fear of victimization since the Federal Law does not recognize the legality of the drug. This will now be a thing of the past if the bill takes home a win but the doctors would have to seek a recommendation from the medical board.

Among the opponents of the bill was Sen. Jay Hottinger, a Newark Republican whose argument was based on lack of adequate proof of the medical benefits of marijuana. Sen. Bill Coley, R-Liberty Township, who was partially in support of the bill, said that it was much better than the proposed Sen. Bill Coley, R-Liberty Township,

In response to Hotlinger’s claims, Sen. Bill Seitz, a Cincinnati Republican said that Marijuana was not as harmful as cocaine. He is calling on all the Republicans to support the measure. At the same time, he is urging the federal government to recall the drug from being a Schedule I dangerous substances.

The signing of the bill by Kasich will give Ohio the 25th position of the states that have legalized medical marijuana. Nevertheless, a spokesman for the Governor’s office could not disclose whether or not the governor was in support of the bill.

Pin It on Pinterest